Health and Healthcare

Monday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

NEURO-HITECH INC [NHPI.OB] +17.36%
LEV PHARMACEUTICALS [LEVP.OB] +11.18%
OBAGI MEDICAL [OMPI] +9.16%
GENVEC INC [GNVC] +7.84%
ACHILLION PHARMACEUT [ACHN] +6.71%

Diagnostic Substances

SCOLR PHARMA INC [DDD] +8.00%
LEXICON GENETICS I [LEXG] +6.97%
ASPENBIO PHARMA INC [APNB.OB] +6.12%
ABAXIS INC [ABAX] +5.98%
ICAGEN, INC. [ICGN] +5.32%

Drug Delivery

FLAMEL TECH SA ADR [FLML] +11.22%
INSITE VISION INC [ISV] +7.55%
QUIGLEY CORP THE [QGLY] +3.79%
DELCATH SYSTEMS INC [DCTH] +3.77%
K V PHARMA CL A [KV-A] +2.85%

Drug Manufacturers

PHARMAXIS LTD ADR [PXSL] +9.69%
NITROMED, INC. [NTMD] +7.99%
ADVANCIS PHARMA CP [AVNC] +5.95%
BRADLEY PHARMACTCL [BDY] +5.70%
ATHEROGENICS INC [AGIX] +5.56%

Medical Appliances & Equipment

SYNOVIS LIFE TECH [SYNO] +5.76%
ROCKWELL MED TECHS [RMTI] +4.97%
ALPHA PRO TECH [APT] +4.91%
NORTH AMERN SCI [NASI] +4.85%
SPECTRASCIENCE NEW [SCIE.OB] +4.72%

Medical Instruments & Supplies

NEPHROS INC. [NEP] +22.85%
OCCULOGIX, INC. [OCCX] +21.33%
MICROMED CARDIOVASCU [MMCV.OB] +14.29%
IMMUNOCELLULAR THERA [IMUC.OB] +13.04%
BIOMIMETIC THERAPEUT [BMTI] +9.97%

Medical Laboratories & Research

MEDTOX SCIENTFIC INC [MTOX] +6.38%
RADNET INC [RDNT.OB] +3.68%
ERESEARCHTECHNOLOG [ERES] +2.87%
GENOMIC HEALTH, INC. [GHDX] +2.83%
QUEST DIAGNOSTC [DGX] +1.61%

http://www.biohealthinvestor.com/

Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.